PIERCING THE VEIL OF SECRECY IN
HIV/AIDS AND OTHER SEXUALLY TRANSMITTED DISEASES: THEORIES OF
PRIVACY AND DISCLOSURE IN PARTNER NOTIFICATION
LAWRENCE O.
GOSTIN*
JAMES G. HODGE, JR.
Part 2
Section:
1
2
3
1. Privacy. Infected persons
have a strong ethical claim to the privacy of their medical
diagnosis, records, and their health status generally.264
Privacy interests, however, are sacrificed when necessary to
reduce a risk to their sex partners. The degree of sacrifice
varies depending upon the form of partner notification. Where
partner notification is performed pursuant to one's duty to
disclose, privacy interests are swept aside since the duty
requires infected individuals to in-
[*pg 63] form their partners of their own health status.265
Although bound to maintain the confidentiality of a patient's
medical records in light of the HCW/patient relationship, HCWs
nevertheless are compelled ethically,266 in limited
circumstances, to inform partners of their exposure to infection
under a duty or privilege to warn.267 Whenever a HCW
is compelled under a duty to warn unsuspecting partners, the
confidentiality of infected individuals is compromised. In most
cases, the fulfillment of the duty to warn requires the HCW to
identify specifically the source of exposure to partners so they
are aware of the actual source of danger.268 Privacy
interests of infected individuals thus are not preserved through
the fulfillment of the duty to disclose or warn.
Contact tracing programs attempt
to preserve the privacy interests of infected individuals in two
principal ways: (1) contact tracing programs are voluntary in
nature;269 and (2) many programs attempt to conceal
the identity of the index case from exposed partners to protect
the index case's confidentiality.270 In reality,
however, neither of these protections are wholly effective in
limiting the incursion on privacy interests. To the extent that
contact tracing is voluntary, the privacy interests of infected
individuals are protected since they can choose not to
participate. Neither infected persons nor their physicians,
however, can avoid their respective duty to disclose or warn.
Since contact tracing offers a means through which partners can
be notified in satisfaction of these duties, participation is
not merely encouraged. Rather, contact tracing presents the
better of three options facing an individual infected with an
STD in many jurisdictions: either notify your partners on your
own without any assistance, await the action of your doctor who
notifies your partners of your infection, or participate in a
contact tracing program where counseling and other assistance is
available. Contact tracing thus can be viewed not so much as a
voluntary choice of individuals, but rather as a preferred
method of satisfying a legal duty.
[*pg 64]
While the success of contact
tracing largely is tied to "the record of public health
officials in preserving the confidentiality of the information
obtained,"271 attempts to conceal the identities of
those who voluntarily participate usually are in vain.272
The maintenance of patient confidentiality through contact
tracing is a factual myth.273
Confidentiality is breached by the mere participation in contact
tracing programs since public health authorities become aware of
the STD status and identity of index cases for the sole purpose
of assisting in the dissemination of exposure information to
partners.274 Many partners independently are aware of
the source of their infection when contacted. Partners who learn
directly or indirectly of the identity of index cases may relay
information about the index case to others. Confidentiality is
also an ethical myth as an infected individual's privacy rights
cannot be preserved where she discloses her private facts to an
agency that intends to disclose that information to partners who
the infected person knows and who likely know her. Persons who
predominantly benefit from confidentiality protections of
contact tracing are often the same persons whose lifestyles
involve risky behaviors with numerous partners whose identities
are either unknown or cannot be recalled over long time periods,
as seen with STDs like syphilis and HIV that have long
asymptomatic periods.275 As a result, pri-
[*pg 65] vacy interests of
infected persons are sacrificed through systematic contact
tracing programs that in reality are not completely voluntary
nor confidential.
2. "Right to Know." Balanced
against the claims of infected persons to privacy are the
equally compelling claims of their partners to be informed of
the risk. Sex partners understandably seek to know unforeseen
dangers of which others are aware.276 Partners claim
a "right" to know that they have been exposed to infection
because (1) knowledge empowers individuals to avoid continuing
risks; (2) knowledge of infection allows for early treatment;
and (3) knowledgeable partners can adapt their behavior to
prevent further transmission of infection to others.277
Just as partner notification does not protect fully the privacy
rights of infected persons, it also fails to protect fully their
partners' privacy rights. Since contact tracing is by its nature
voluntary, index cases are not compelled to participate. Even
when index cases choose to participate, they do not have to
provide the names of any or all partners, or even to notify
partners under patient or conditional referral programs. In
addition, a high percentage of partners cannot be located due to
inadequate or incorrect information volunteered by index cases.
Conditional and provider
referral programs do not actually provide the names of the
sources of potential infection to partners, thus leaving some
partners with inadequate information to protect themselves fully
against a known threat. Although counseling is offered on how to
protect oneself against STD infection, not all persons notified
of their exposure choose to receive counseling. Some partners,
therefore, relinquish their own right to know. Under patient,
provider, or conditional referral programs, many partners thus
are not informed completely about their risk of infection.
While the exercise of a duty to
disclose imposed on infected individuals or a duty to warn
imposed on HCWs would resolve some of the weaknesses of contact
tracing programs by specifically notifying partners of the
sources of their exposure, such duties do not result in reliable
notification of partners. Infected individuals regularly ignore
their legal duty to disclose without being subjected to
significant legal ramifications. HCWs also can be reluctant to
notify even when required to do so, as laws that specify when
HCWs have a duty to warn can be lofty and difficult to measure.
Strong confidentiality measures concerning patient records and
medical information, and the threat of legal and administrative
action for unnecessary breaches of confidentiality prevent many
[*pg 66] HCWs from warning
partners.278 Privilege to warn statutes allow HCWs
the option of warning in some cases without legal sanctions
either for breaches of confidentiality or for failures to warn.279
3. Normative Analysis. Both
infected persons and their partners can make normative claims
about invasion of autonomy. Persons with infection suggest that
principles respect for autonomy militate in favor of privacy.280
Individuals have the right to control the use of health
information.281 Furthermore, "[t]he principle of
respect for autonomy . . . includes the right to decide insofar
as possible what will happen to one's person -- to one's body,
to information about one's life, to one's secrets, etc."282
A patient's health status, it is argued, ought not to be
disclosed without their consent.283 Partners also
appeal to autonomy in claiming a right to know. Partners cannot
make rational, autonomous choices in the absence of relevant
information.
Both parties base their
normative arguments on the principle of autonomy. However,
autonomy, when properly understood, favors the partner's claim.
Autonomy supports certain legitimate claims to personal
information and decisionmaking for which others interests in
confidentiality are insufficient to withhold information.284
Autonomous individuals have the right to engage in behaviors of
their choosing.285 The autonomous interests of
infected persons, however, are not absolute.286
Autonomy, in its most traditional sense, does not extend to
behavior that can result in serious harm to others.287
A person with HIV infection has no legitimate ethical claim that
maintaining her confidentiality [*pg
67] justifies failure to protect others from potential
harm, especially where the threat of harm is imminent or the
consequences of such harm particularly are serious.288
The claim of partners to
adequate information necessary to support an autonomous decision
is stronger. Partners who engage in sexual relations cannot act
rationally without knowledge of the consequences. While a
partner is free to consent or refuse sex, that choice is
meaningless unless it is made with reasonable knowledge of the
risks. Partner notification, then, may be justified by a
partner's autonomy right to truthful information to guide their
behavior.
4. Consequentialist Analysis.
Consequentialist theory supports adopting policies that, on
balance, produce the greatest benefit for populations as a
whole.289 The balance of the ethical claims of
infected individuals to their privacy and of partners to know
depends on the extent to which the recognition of such claims is
likely to lead to improved health among the general population.
Determining the balance between these competing interests is
complex. The objective is to balance the respective interests of
infected persons and their partners in such a way that societal
health is maximized. What remains unresolved is whether partner
notification represents the proper balance.
Many partners believe that their
chances for preserving their individual health rely in
substantial part on notification of risk. It follows, they
argue, that universal notification would improve all partners'
chances. Yet, many infected persons, particularly women, counter
this observation by documenting the costs of partner
notification on infected individuals. Retribution in the form of
domestic violence and abuse is a serious consequence of partner
notification.290 In addition, there is a legitimate,
unresolved concern that universal partner notification would
drive infected persons underground, effectively hiding their
STD-positive status from virtually everyone, including partners,
doctors, and family members. Determining whether partner
notification provides a net benefit to relevant populations
truly depends on its efficacy. Privacy rights of infected
individuals should yield only if partner notification works
meaningfully to alter risk behaviors and to reduce the incidence
of HIV and other STDs. This requires a systematic empirical
analysis that is discussed later in this Article. 291
[*pg 68]
B. Feminist Theories and
Sexual Ethics
Feminists have long supported
the idea that women should be informed about their sexual risks.292
In many ways, feminist theory simply reinforces the normative
arguments previously discussed because women claim that they
cannot make autonomous decisions absent critical information
regarding risks they face. However, there are several
characteristics of sexual transmission of diseases that suggest
a distinct feminist perspective. For reasons of biology,
epidemiology, and vulnerability, the "right to know"
particularly is pertinent to women.
From a biological perspective,
women have an elevated risk, as compared to men, of contracting
disease within the context of a heterosexual relationship.293
Some STDs, such as syphilis, are more difficult for women to
detect than men.294 This increased biological risk
also can be seen epidemiologically. Women currently comprise one
of the fastest growing groups of people with HIV/AIDS,295
with increased infection rates seen most heavily among minority
women.296
In addition, women are much more
vulnerable within relationships, often being economically
dependent and subject to physical and psychological abuse.
Partner notification assumes that individuals can control their
[*pg 69] exposure to the disease.297 Many women,
however, lack control over their own exposure because of their
inability to make critical life choices due to poverty, domestic
violence, and discrimination.298 Women may lack the
power in their relationships to require male partners to refrain
from sex or to use condoms.299 Partner notification
programs that focus on the role of individuals as agents in the
effort to control epidemic STDs may neglect the status of women
who societally are dependent on their partners, and thus do not
possess the same amount of control over their risk of exposure
as most men do.
To the extent that public health
strategies reflect a masculine structure of personal
responsibility, they ignore the reality of many women's lives,
including the imminent threat of physical abuse at the hands of
notified male partners. Researchers have identified a strong
link between AIDS and violence that for women translates into an
epidemic potential for domestic abuse.300 Where
partner notification has the potential to result in domestic
violence against women, "[t]he risk of physical harm to the
female patient from her partner may be greater than the
potential benefit of warning the partner."301
Even if women do have the
economic and physical power to require changes in the sexual
behavior of their partners, they may not be aware of the risks.
Women often do not know they are at risk, or only learn of their
positive [*pg 70] status when
a partner or child is diagnosed with, or dies from, AIDS.302
In the HIV epidemic, the greatest risks to women are from males
who are bisexual303 or injecting drug users.304
Yet the risk status of men is not apparent and often requires
some formal notification.
Feminist theories, despite all
their degrees and differences,305 agree that "the
evaluation of medical practices must give primary
attention to the impact of such practices on women -- not
just on individual women but on women as a group, including
especially disadvantaged women such as poor women and women of
color."306 The HIV/AIDS epidemic has presented a
modern challenge to the premises on which feminist support of
partner notification is grounded. Although HIV/AIDS generally
has been viewed as a gay disease,307 societal views
of HIV-positive women have at times been unbecoming. Consistent
with traditional societal views of female prostitutes throughout
the syphilis epidemic, [*pg 71]
women have been viewed as "vectors"308 of disease who
infect unsuspecting men or children. The rise of heterosexual
and vertical transmission of HIV was attributed in part to
women.309 And like other high-risk groups,
HIV-positive women became silent victims of the disease as
society initially chose to protect the confidentiality of
seropositive individuals over female partners' right to know.310
Feminists demand that partner
notification, like many government-sponsored programs, be
analyzed by asking about its specific effects on women. As
Katherine T. Bartlett explains:
[A]sking the
woman question means examining how the law [or regulation] fails
to take into account the experiences and values that seem more
typical of women than men, for whatever reason, or how existing
legal standards and concepts might disadvantage women. . . . The
purpose of the woman question is to expose those features and
how they operate, and to suggest how they might be corrected.311
Feminists evaluate the models of
partner notification in the context of the reality of women's
lives to protect women as partners, who may not know they are at
risk of infection, and to protect women as patients, who must
contend with economic dependence and domestic violence. Although
notification is important, it may increase the likelihood of
harm suffered by women as patients who are dependent
economically or who suffer from abuse, and concurrently oppress
women by prohibiting them from making their own choices.312
Partner notification from a
feminist perspective is both favored because it gives women
vital knowledge to protect themselves and disfavored because it
potentially exposes women to violence. Some women face
consequences including domestic abuse, abandonment, and economic
misfortune as a result of notification. Although feminists
generally support partner notification in its effort to notify
women at risk of infection, they question the development of the
methods through which it is accomplished as unresponsive to
women's needs.
[*pg 72]
V. EFFICACY OF PARTNER
NOTIFICATION
A. Public Health Efficacy:
Empirical Analyses
A partner's claim to knowledge
of health risks predominantly supports partner notification.
Legal analysis holds that information concerning risks to which
partners are exposed justifies the duties to disclose and warn
and contact tracing, despite infringements on the privacy
interests of infected individuals.313 Normative
analysis favors partner notification because individuals have a
legitimate claim to fundamental knowledge necessary to protect
their own health.314 Partner notification, however,
cannot rely on the moral "right to know" and legal duties alone.
Consequentialist and feminist theories expose weaknesses in the
support for partner notification. Infected women face the darker
side of partner notification, suffering physical, emotional, and
economic abuse from the dissemination of information to their
male partners. Consequentialism requires objective proof of the
efficacy of partner notification even though it commonly is
assumed to be an effective public health strategy.
Partner notification as a public
health practice demands more than subjective proof of efficacy.
Scientifically-verifiable and demonstrably-sound proof that
partner notification actually reduces the risk of infection is
required. To be effective, partner notification must accomplish
substantially its intended goals. First, partner notification
must advise partners of the risks of harm so they can make
informed choices to reduce the risks. Under this view, even if
contacts do not alter their behaviors, there is a positive value
in enhanced autonomy. It is necessary to devote a great deal of
attention to this first goal. Under the prevalent methods of
contact tracing, patient and conditional referral, data suggest
that partners often are not informed. In such cases, there
clearly is no positive value to partner notification. When
partners are informed, at least the normative value of providing
this information to autonomous individuals is accomplished.
Second, and more important,
partner notification is designed to protect the public health.
If partner notification reduces the rate of STD infection as
well or better than other public health interventions, it may be
regarded as effective. The central question, therefore, is
whether partner notification accomplishes the goal of reducing
STD transmissions as part of a national, comprehensive public
health strategy. Do the notification, education, counseling,
testing, and treatment services provided as part of contact
tracing programs reduce the transmission rate of STDs, and, if
so, at what cost and how? Answering this question is complex.
Some studies suggest that partner notification is effective in
limited environments involving high-risk populations.
Scientifically-objective proof of the efficacy of contact
tracing as a widespread public health practice, however, is
inconclusive. The accumulated data suggest that partner
notification as a national practice to control HIV infection
does not work nearly as well as is claimed by its proponents. As
a result, support for partner notification based on moral[*pg
73] and legal claims to information loses force where
partner notification does not actually serve public health
goals.
Examining the scientific
efficacy of partner notification is not a simple task. Efficacy
is largely an empirical question. Measuring the effectiveness of
partner notification through contact tracing is problematic.315
No scientifically valid empirical standard exists to measure the
effectiveness of contact tracing as applied to STDs across large
populations. The consensus of opinion instead holds that
"[a]ctive contact tracing programs have been effective (but
costly) in controlling localized outbreaks of specific
antibiotic resistant strains of sexually transmitted diseases
with short latency periods and in targeting specific subgroups
of the population."316 Studies suggest that STDs such
as syphilis,317 gonorrhea,318 and
chlamydia319 have been controlled among subgroups
through contact tracing. Contact tracing in the context of
HIV/AIDS has been challenged on the basis that finding and
notifying partners is less effective than with other STDs since
there is no cure for AIDS320 and the long
asymptomatic incubation period of the infection makes tracing
difficult among populations.321 These observations,
however, do not justify a failure to attempt to notify persons
at risk of HIV infection. While AIDS remains a terminal
condition, new pharmacological interventions can prolong the
life of an HIV-infected individual by delaying symptomology.322
In addition, although it may be difficult to notify former
partners of HIV-infected persons, those who are notified are
likely to have been more recently exposed to infection,
rendering counselling and treatment services more useful for the
con- [*pg 74] tact and
potential future partners.323 Clearly, "[t]he key
issue remains not whether sex and needle-sharing partners of
HIV-infected individuals should be informed, but rather how this
notification will occur."324
Public health studies suggest
that HIV partner notification programs can be effective in
locating and counseling infected contacts of index cases325
and in reducing STD infection rates,326 particularly
among at-risk groups.327 These findings often focus
on preserving the confidentiality of index cases.328
For example, a study conducted in the United Kingdom in 1993
found partner notification in the form of a voluntary provider
referral program where confidentiality was preserved to be an
effective strategy for identifying individuals at risk of
becoming infected with HIV and providing them with access to
counseling and health care.329 Twenty-nine new index
cases were identified over a seven-year period in a mid-sized
community from seventy-nine original index cases, for a
seropositivity rate of 31.6%.330
The seropositivity rate
describes the percentage of contacts identified through partner
notification in a given program who test positive for HIV for
the first time as a result of their notification.331
In general, the higher the seropositivity rate, the greater the
efficacy of contact tracing as claimed by public health
[*pg 75] authorities.332
The seropositivity rate in the United Kingdom study, for
example, compares favorably to the reported rates of contact
tracing programs in Sweden (15%)333 and Norway (13%).334
Comparing seropositivity rates as a measure of efficacy,
however, is unsound. Variances in reported seropositivity rates
are likely the result of generally incomparable factors,
including: (1) the demographics of the population being studied;
(2) the culture of the society in which the studies are
conducted; (3) the means of operating particular contact tracing
programs; (4) the length of time over which the study is
conducted; (5) the period in time in which the study is
performed; and (6) the sample size of the program studied.335
This is not to say that reported seropositivity rates of studies
on the efficacy of partner notification are of no value.
Reported rates can demonstrate the efficacy of different contact
procedures within internal studies336 or in
comparison to other public health measures in the same
community.337 Seropositivity rates of contact tracing
programs, however, largely are incomparable across populations,
methods, and time.
A second fallacy of comparing
seropositivity rates as an affirmation of efficacy is that it
looks past a primary function of contact tracing, that is,
actually notifying and counselling partners. Efficacy studies in
Oregon338 and North Carolina339 involving
syphilis and HIV, respectively, concluded that partner
notification is unsuccessful in containing STDs where many
potential contacts cannot be notified due to the inability of
index cases to identify their numerous sexual and drug partners.
In actuality, the ability of contact tracing programs to locate
[*pg 76] partners of index
cases infected with STDs such as syphilis and HIV that have long
latency periods is minimal. Since seropositivity rates are
calculated only among those partners who are located, the rates
do not reflect the prevalence of disease in a community or the
effective ability of contact tracing programs to actually trace
all, or even most, partners. Seropositivity rates are thus an
inaccurate means by which to judge the efficacy of partner
notification.
The confidentiality of index
cases who voluntarily participate in contact tracing programs is
a critical issue of law and ethics.340
Confidentiality has been an appropriate focal point of modern
studies examining partner notification efforts involving
HIV-positive individuals; these studies stress the importance of
confidentiality in the operation of contact tracing programs. A
1991 Colorado study found a twofold difference in seropositivity
rates of newly tested contacts between those HIV-infected index
cases who were tested at confidential testing sites versus those
who were tested at anonymous testing sites.341 In
addition, in North Carolina, an internal, comparative study of
contact tracing programs randomly assigned index cases to
participate in a provider referral program (where
confidentiality was guaranteed) and patient referral program
(where confidentiality was not).342 Adequate
counseling was provided to both groups to encourage the
identification and notification of all sexual and needle-sharing
partners. Of those who were assigned to provider referral
programs, fifty percent of the named partners were located and
notified by public health counselors. This compared favorably to
the patient referral group where only seven percent of partners
were notified, despite the state legal requirement that infected
persons notify their partners directly or through a contact
tracing programs.343
While these studies demonstrate
the importance of maintaining the confidentiality of index cases
in contacting partners, they do not prove that confidentiality
actually is maintained. They simply allege that where
confidentiality protections are furnished initially, as through
provider referral, index cases are more likely to participate in
partner notification. As this Article has argued, preserving the
confidentiality of index cases through partner notification is a
factual and ethical myth. Were index cases advised of this
conclusion prior to their participation in a provider referral
program, the studies suggest they will not participate
voluntarily. While preserving confidentiality is thus an
important factor in improving the efficacy of partner
notification, studies that reach this conclusion without proving
that confidentiality ultimately is preserved are flawed. It is
scientifically and ethically inconsistent to advocate the
efficacy of [*pg 77]
confidential partner notification where confidentiality is
assured falsely to voluntary participants.
The degree to which partner
notification works to alter favorably the behavior of at-risk
individuals also is unclear. A study in South Carolina
systematically attempted to demonstrate the effectiveness of
partner notification in altering the at-risk behaviors of
contacts.344 Partner notification services in a rural
South Carolina district included voluntary follow-up interviews
with HIV-positive and HIV-negative contacts at six-month
intervals, which provided an opportunity to measure behavioral
changes in such individuals. Through these interviews, the
authors tabulated the number of sexual and needle-sharing
partners reported by prior contacts before and after partner
notification services. Marked decreases in the number of sexual
partners were reported: of those HIV-positive individuals who
were re-interviewed at least once, reported partners decreased
from an average of 5.6 per case to 1.1 per case after partner
notification, an eighty percent decrease. HIV-negative
individuals reported on average fifty percent fewer partners
after partner notification.345 While these findings
are promising, they lack demonstrative proof of decreased
at-risk behaviors, and fail to represent the behavioral trends
of many partners who chose not to participate in the follow-up
interviews.
Noting a lack of evidence
regarding the impact of testing and counseling on sexual
behaviors, a group of Canadian researchers examined several STD
notification studies in 1994 in an attempt to determine the
effectiveness of various partner notification models.346
Their findings were, not surprisingly, inconclusive, as "there
has been a paucity of well designed studies to evaluate the
effec- [*pg 78] tiveness of
partner notification strategies."347 The authors
noted that, "there is very little upon which to estimate the
ultimate benefits and harms of partner notification for HIV
infection," and further that, "arguments for and against
provider referral for HIV infection tend to be based more on
convictions than on data."348 As a result, they
recommended that policy decisions regarding partner notification
be based on grounds other than efficacy.349
The Canadian report illuminates
a major dilemma in examining the efficacy of contact tracing. It
is extremely difficult (or nearly impossible) to measure
efficacy accurately with so many variables to calculate. While
virtually all studies on partner notification efficacy report
disparate rates of seropositivity, none suggest that high rates
of seropositivity among contacts of HIV index cases is an
exclusive determinant of the efficacy of the program. Whether
partner notification actually reduces the rate of HIV
transmission through behavioral change remains largely
speculative.350 As part of a national comprehensive
public health strategy, partner notification has not been proven
scientifically to reduce the rate of HIV infection among the
general population or alter the at-risk behaviors of index cases
or partners alike.
B. Economic Perspectives:
Cost-Effectiveness and Incentives for Behavior Change
With limited financial resources
devoted to public health efforts to combat STDs, including HIV,
economic justifications for each part of the comprehensive
strategy are essential. Strategic elements that produce
demonstrably sound, cost-effective benefits are attractive to
those who appropriate funds for such efforts, to the exclusion
of other, less economically viable elements.351 Yet,
economic analysis cited in support of partner notification often
is misguided.
"Savings" in the form of medical
treatment costs foregone by the alleged prevention of infection
of others as a result of partner notification often is cited
[*pg 79] as economically
justifying such efforts.352 Partner notification
programs are analyzed under cost-benefit principles by
calculating the cost per new case identified. This figure is
deemed important because identifying a new index case through
partner notification may mean that future cases of infection
will be prevented since index cases are counseled on how to
prevent infecting others. In addition, with STDs other than HIV,
where curative treatment presently is available, identifying and
treating an infected individual effectively can break the chain
of transmission. The lower the cost of new case identified, the
more economically sound a program is judged to be, principally
because the costs of prevention are much lower than the costs of
treating people once they have become infected.353
Comparing the costs of
identifying new index cases to the costs of treating future
infected persons if index cases go unidentified is senseless
from the public health perspective. Not only do such comparisons
completely fail to address whether partner notification results
in positive behavioral changes among those notified, the
comparisons ridiculously suggest that if it takes X dollars to
treat an HIV-infected individual, it is cost-effective to spend
X - 1 dollars to prevent such infections through partner
notification. Public health authorities will not deny that
spending resources on efforts to prevent the transmission of
STDs has positive cost-benefits, provided an adequate number of
infections are prevented.354 With limited resources
devoted to public health efforts to control STDs, however, funds
must be allocated to efforts that most effectively reduce
infection rates. Partner notification is not "the sole strategy
for preventing [STD] transmission."355 To the
contrary, it is a part of a comprehensive public health strategy
that includes testing, screening, and reporting services,
largely funded by the [*pg 80]
CDC.356 It is important, therefore, to examine the
opportunity costs of expending limited resources on partner
notification to the exclusion of other strategies that may be
more effective. Regardless of cost-benefit analyses, the
economic inquiry should be whether X dollars spent on partner
notification could be used more efficiently to accomplish public
health goals through other strategies such as health education
or condom distribution. Unfortunately, comparative economic
studies examining partner notification against other strategic
public health efforts to control STDs virtually are
non-existent.357
There is still a finer economic
question to be examined. Economics is a scientific theory used
to predict rational human behavior.358 At its core,
it is the science of rational choice in an environment of
limited resources in relation to human wants.359
Under this view "[t]he task of economics, so defined, is to
explore the implications of assuming that man is a rational
maximizer of his ends in life, his satisfactions -- what . . .
shall [be] call[ed] his 'self-interest.'"360
Individual behavior is rational when it adheres to economic
principles of rational choice.361 The economic
question concerning partner notification is the degree to which
it influences individual behavior so as to produce rational
decisions that accomplish public health objectives.
In their controversial economic
analysis of the AIDS epidemic in which they argue that public
health education manipulates and interferes with rational
decisionmakers, Tomas J. Philipson and Richard A. Posner
conclude that CDC programs (such as contact tracing) that
identify disease transmission may increase the spread of
disease.362 They envision sexual encounters and
relationships under their rational choice model as "trade[s] in
the standard economic sense of an activity perceived as mutually
beneficial to the persons engaged in it."363 They
argue that people will engage in risky behaviors in an
economically rational fashion; a person will participate in
sexual acts placing them in danger of HIV infection where the
actor's expected utility or subjective welfare is maximized.364
Since individuals will act according to the determination of
their own maximum utility, Philipson and Posner argue that the
threat of HIV infection will alter in-
[*pg 81] dividual risky
behavior differently.365 In the face of an incurable
disease like HIV/AIDS, those who choose risky sex essentially
value it over life.366
Predicting in 1993 that the
United States population is approaching an economically
efficient level of HIV infection,367 Philipson and
Posner have been described as arguing that368
state
intervention to fight AIDS is presumptively unwarranted. . . .
[They further argue] that mandatory testing for HIV is not worth
the cost (in terms of, among other things, privacy) and could
well be counterproductive; that the state is probably spending
far too much money on research for vaccines, cures, and
treatment; and that some money should be spent on targeted
education programs that facilitate the operation of people's
rational calculations.369
The economists were critical of
testing for HIV, arguing that testing actually increases the
spread of HIV infection, as uninfected persons are lulled into
risky behaviors after testing negative and some infected
individuals hide their disease from partners despite testing
positive.370 Philipson and Posner argue that to the
extent that contact tracing results in additional testing of
contacts, partner notification may contribute to the spread of
HIV.371
Though imaginative, Philipson
and Posner's economic assessment of partner notification as
contributing to the spread of HIV is neither supported by
empirical data nor accepted by public health authorities.372
No study has found an increase in overall HIV infection rates
based on increased HIV testing or partner notification.373
Allowing the HIV epidemic to run its course, as Philipson and
Posner suggest, is unfounded and inconsistent with public health
practice. Unlike the non-interventionist nature of economic
strategies, public health efforts, like partner notification,
necessarily are interventionist. Where persons are dying of a
preventable disease, public health interventions not only are
compelling, but also are practical where early identification
may benefit the infected through clinical intervention,
particularly in the case of perinatal transmission of HIV.374
While economic justifications for partner
notification in the form of cost-benefit analyses are off
target, it equally is negligent to suggest that partner
notification actually contributes to increased incidences of STD
infection. The answer to the true economic question of whether
partner notification is more or less effective, in comparison to
other elements of a comprehensive public health
[*pg 82] strategy, largely is
unknown. As a result, supporting partner notification as a
national practice on an economic basis alone is illusory.
VI. ALTERNATIVE MODELS FOR
PARTNER NOTIFICATION
Despite the moral and legal
claims supporting partner notification, impediments to
implementing it as a widespread practice abound. In addition to
its general failure to protect confidentiality, state operated
contact tracing programs are not perceived by infected
individuals as voluntary, in light of judicially enforced duties
to disclose and warn, but rather as options to
self-notification. In this sense, partner notification has a
mandatory nature that discourages participation. Lack of
participation is one determinant of the essentially unproven
efficacy of partner notification efforts. Although partner
notification is an accepted practice both ethically and morally,
its unproven efficacy reflects the reality that administrating
morality is problematic. Cost-benefit analysis projects positive
returns on dollars spent on partner notification, but in the
economic sense, such programs suffer from a lack of demonstrable
evidence that the services provided are the most cost-effective
available or actually result in behavioral modification. These
facts, coupled with the real world potential of partner
notification to cause more harm than good, especially as
experienced by STD-positive women and other disadvantaged
persons who may suffer mental and physical harm, societal
discrimination, and personal economic ruin, challenge the public
health conception of partner notification as a valid and useful
tool.
Partner notification represents
the weak link in the comprehensive public health strategy to
prevent STD transmission. Worse yet, it actually may hinder
persons from being tested for STDs. Although more studies about
the effectiveness of partner notification are necessary given
its long-standing use, present evidence suggests that partner
notification at best represents an antiquated and largely
ineffective public health intervention when implemented
nationally. As a result, other public health measures should be
examined to determine if they can be utilized more effectively
to combat STDs without the drawbacks of partner notification.
A. Partner Notification as
Part of Public Health Surveillance and Prevention Strategies
Partner notification cannot be
viewed outside the context of a broad range of public health
strategies designed to prevent transmission of STDs. Contact
tracing, for example, can only be effective if individuals at
risk are tested early in the course of their infection and if
positive cases are reported to health authorities. If
individuals and health officials have no knowledge of their STD
status, the issue of partner notification does not arise.
Testing involves the
administration of a diagnostic test to determine whether
individuals have contracted a particular infectious condition.375
Tests [*pg 83] exist to
diagnose virtually every known STD,376 although the
effectiveness and costs vary for each STD.377 In the
case of HIV, a serologic test for the disease was not developed
until 1985;378 later, the CDC would recommend pre-
and post-test counseling379 and medical intervention380
as integral parts of HIV testing. Despite opposition from AIDS
service organizations, who argued that testing would lead to
greater discrimination,381 millions of HIV serologic
tests have been performed at publicly-funded testing sites,382
including family planning clinics, tuberculosis clinics, drug
treatment centers, and primary care clinics.383 The
main purpose of testing for STD infection as part of the
comprehensive strategy is to diagnose and treat persons to
prevent further transmission.384
Testing, however, like partner
notification, is not exclusively a function of public health
authorities. Many private health care providers provide testing
services for individual patients.385 Still others
seek testing for STDs, including HIV, test themselves
anonymously using home collection tests.386 Private
testing methods allow individuals to learn of their STD status
in a confidential setting outside public health clinics,
hospitals, managed care organizations, and private physician
offices. The primary disadvantage of home testing, from a public
health perspective, is the lack of opportunity to provide
positive, non-directive counseling concerning the psychological
effects of testing, opportunities for treatment, and strategies
for behavior change.
While testing services
concentrate on diagnosing infection among consenting individuals
who request or seek such services, screening programs attempt to
determine infection through tests administered to groups at risk
of disease or [*pg 84] other
sub-populations.387 Screening, which refers to the
"systematic application of [diagnostic tests] to specific
targeted populations,"388 is implemented to diagnose
individuals who are or may be at risk of contracting an STD or
who would pose a threat to others. An example is the screening
practice of premarital syphilis tests dating back to the 1930s.389
Modern STD screening programs target persons who utilize family
planning and adolescent health clinics for STDs like chlamydia.390
Since patients at STD and drug treatment centers may have an
elevated risk, these centers are frequently the focus of
screening programs.391 Mandatory screening programs
involving such individuals, however, have been criticized as
ineffective at accomplishing the public health objective of
modifying at-risk behaviors.392 Individual counseling
and therapy on a voluntary basis, therefore, are recommended as
a corollary to screening programs.393
Where testing and screening
procedures identify cases of STD infection among individuals,
reporting requirements mandate that these cases be relayed to
state authorities.394 Reporting, which can be named
or non-named and coded to prevent dissemination of private
information, exists at all levels of public health.395
Reporting requirements are justified by the need to track the
prevalence and incidence of STDs across populations.396
Disease patterns and trends determined through state reporting
assist authorities in their efforts to allocate limited
resources devoted to preventing STD transmission.397
Information gained through reporting also may assist in
measuring the efficacy of public health efforts to control
particular STDs. Mass educational campaigns can be targeted to
at-risk groups, and named reporting can be a direct link to
offering [*pg 85] partner
notification services to infected individuals who otherwise have
not been located through public testing and screening.398
Although STD reporting
requirements differ from state to state, all states require
reporting for STDs, including syphilis, gonorrhea, chlamydia,
chancroid, and hepatitis B.399 Private providers,
however, often fail to comply with reporting requirements.400
AIDS reporting is required in all states, and more than half the
states have reporting requirements for HIV.401 This
policy decision of states to not require HIV reporting is in
part reflective of the vocal concerns of community advocates
about infringements on privacy interests resulting from the
systematic reporting and collection of confidential information
by government.402
While many infected persons can
be identified and assisted through testing, screening, and
reporting requirements, partner notification is intended to
supplement these methods. Partner notification is an accepted
component of the comprehensive public health strategy where
testing and screening programs identify infected individuals,
the names of infected persons are reported to state public
health authorities who track the spread of the disease, and
contact tracing assists individuals in notifying their partners
of the risk of infection. Testing is recommended for all
partners notified and the strategic process is begun again.
Throughout the process, counseling and education are stressed to
modify individual risky behaviors.
As one component of the strategy
designed to reach persons at risk of infection who may not
otherwise be aware of their exposure or inclined to modify their
at-risk behavior, partner notification lacks proof of efficacy
and unnecessarily imposes serious infringements on individual
rights and interests. Alternative approaches to partner
notification can achieve the same public health objectives more
efficiently with less intrusion on personal liberty and privacy
interests.
B. Utility of Alternative
Approaches to Partner Notification
While the national practice of
partner notification may be challenged, the need to inform
at-risk persons of dangers of which they may be unaware is
indisputable. The value of collecting information from infected
individuals and notifying those at risk is clear. It is the
method of notification that comprehensive analysis of partner
notification brings into dispute. As an alternative to di-
[*pg 86] rect partner
notification, information gained through the channels of partner
notification, that is through infected individuals, can be used
to focus educational and notification efforts in a confidential
manner on persons at risk, including partners.403
While some public health authorities suggest developing focused
educational programs for people at high risk for STD infection404
or street/community outreach programs405 as
alternatives to partner notification, others propose using
information gained through the traditional practice of partner
notification to ascertain the at-risk behaviors of all
individuals within a group or sub-population at risk.
Through methods similar to
modern business marketing principles, most applications of
contact tracing in its present form can be replaced with social
network analysis (SNA).406 Complex in practice, SNA
attempts to measure the way in which people relate to each other
by examining determinants of their social structure, or network.
It transforms information obtained from individuals through
interviews, surveys, or epidemiologic studies into data about
their interaction within networks.407 Complementary
approaches of network ascertainment and ethnography are combined
to describe "a social process, such as the transmission of
disease, and to contribute to disease control and program
evaluation."408 Instead of concentrating on
information about partners, as traditional contact tracing does,
SNA attempts to identify persons in an infected individual's
social setting and offer epidemiologic treatment (testing and
medical evaluations) to STD network members discovered through
ethnographic analysis.409 Further analysis allows
authorities to target public health efforts at those who are
calculated to be at the greatest risk of infection.410
Some of the benefits of SNA over
traditional contact tracing include: the ability of public
health authorities to focus efforts on persons at greatest risk
of STD infection; the development of enhanced knowledge about
existing transmission rates within defined areas and
sub-populations that "brings disease control closer to the
starting line;"411 the advantage of not being
required to inquire specifically about partners of infected
persons; the provision of important information to at-risk
individuals without breaching the confidentiality of sources;
the [*pg 87] ability to
identify and notify persons at risk who are not necessarily
former or existing sexual or IDU partners of infected persons,
but may be in the future; and the ability to develop more
detailed information about at-risk behaviors to allow more
effective behavioral interventions.412
There are disadvantages to SNA
as well. First, the approach is dependent upon information
gathering, and thus is labor intensive, expensive, and
time-consuming.413 This drawback also is true of
provider referral, which is perhaps the most efficacious form of
contact tracing. Second, if the information is incomplete or
incorrect, network behavioral calculations may be off target.
Third, SNA requires technologically-advanced statistical
calculations by knowledgeable experts to which smaller public
health districts may lack adequate access. New statistical
methods that simplify the deduction of individual behavior from
aggregate data without affecting accuracy, however, may prove
valuable in epidemiological applications like SNA.414
Fourth, network techniques also may be incompatable for
differing STDs and difficult to replicate in all communities.415
Fifth, since SNA does not undertake to notify partners directly,
participation by infected persons does not satisfy their legal
duty to disclose; HCWs cannot refer infected patients to SNA
programs to fulfill their duty to warn. Finally, like contact
tracing, the efficacy of SNAs in the field of epidemiology
remains unclear.416
Innovative strategies like SNA,
nonetheless, demonstrate new guidance for public health efforts.
In weighing the benefits of SNA and the drawbacks of contact
tracing, public health authorities should consider SNA in
combination with contact tracing on a reduced scale, limited to
those environments in which contact tracing is demonstrated to
be more effective.417
VII. CONCLUSION
From its origins in the practice
of reglementation to its development during the syphilis
epidemic to its modern application in the HIV/AIDS epidemic,
partner notification has been motivated by the moral imperative
to notify and protect persons who are unaware of their risk of
STD exposure. Few people question the underlying morality of
open and honest information in relation to a "hidden epidemic."
The consequences of partner notification are complex, however,
and are not uniformly beneficial to infected persons, their
partners, and the community. Even though the practice is
defensible on normative grounds, partner notification has
demonstrable flaws. Partner notification presents a cost to
individuals in loss of privacy and in discrimination. For women,
it can result [*pg 88] in
abandonment, neglect, and abuse. In addition, research data do
not demonstrate convincingly the effectiveness and economic
benefits of partner notification. For these reasons, alternative
strategies like social network analysis should be considered to
supplement or replace partner notification. Social network
analyses, involving focused education and notification of
sub-populations at high risk, may change risk behaviors without
infringing civil liberties.
As seen in
the syphilis epidemic, and now experienced in the fight against
HIV, STDs strike vulnerable populations and pose a complex
dilemma between civil liberties and public health. HIV/AIDS
eventually will become a chronic, manageable disease, but its
immediate lesson is clear: public health efforts must be modeled
within societal realities. Relics of the past, such as contact
tracing, must conform to modern understandings of privacy,
women's rights, and perhaps most important, a rigorous
determination of public health efficacy and cost-efficiency.
Section:
1
2
3
|